Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs
Author:
Funder
National Human Genome Research Institute
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health(social science)
Link
https://link.springer.com/content/pdf/10.1007/s11673-021-10119-x.pdf
Reference176 articles.
1. Abdul-Ghani, M.A., C. Puckett, C. Triplitt, et al. 2015. Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the efficacy and durability of initial combination therapy for type 2 diabetes (edict): A randomized trial. Diabetes Obesity & Metabolism 17(3): 268-275.
2. Abraham, J. 2010. On the prohibition of conflicts of interest in pharmaceutical regulation: Precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O’Donovan and Lexchin. Social Science & Medicine 70(5): 648-651.
3. Abraham, J., and R. Ballinger. 2012. Science, politics, and health in the brave new world of pharmaceutical carcinogenic risk assessment: Technical progress or cycle of regulatory capture? Social Science & Medicine 75(8): 1433-1440.
4. Abraham, J., and C. Davis. 2009. Drug evaluation and the permissive principle: Continuities and contradictions between standards and practices in antidepressant regulation. Social Studies of Science 39(4): 569-598.
5. ACCORD Study Group. 2011. Long-term effects of intensive glucose lowering on cardiovascular outcomes. New England Journal of Medicine 364(9): 818-828.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prepregnancy Health Care Engagement Among American Indian and Alaska Native People Before and After the Affordable Care Act;Health Equity;2024-05-01
2. Drivers of medicalization in the Canadian Adult Obesity Clinical Practice Guidelines;Canadian Journal of Public Health;2022-07-15
3. The Pensive Gaze;Journal of Bioethical Inquiry;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3